Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « June » « 2025 » M T W T F S S 26 27 28 29 30 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4 5 6   - « June » « 2025 » M T W T F S S 26 27 28 29 30 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4 5 6   Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
BENSA, Caroline
BABYZUMAB-2, NCT05209815: Safety of Exposure to Natalizumab During Pregnancy	Completed	N/A	68	Europe, RoW	Questionnaire	University Hospital, Bordeaux, Biogen	Multiple Sclerosis	12/23	12/23

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
BENSA, Caroline
BABYZUMAB-2, NCT05209815: Safety of Exposure to Natalizumab During Pregnancy	Completed	N/A	68	Europe, RoW	Questionnaire	University Hospital, Bordeaux, Biogen	Multiple Sclerosis	12/23	12/23